CINGW

Cingulate Inc. CINGW

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CINGW KALA PHIO APVO COCP ERNA TVGN BOLT INAB EVGN
6M -11.11 % -59.37 % -17.04 % -91.21 % -19.85 % -52.17 % -26.01 % -9.56 % -54.97 % 38.62 %
YTD -34.10 % -81.71 % 17.89 % -98.28 % -54.74 % -76.17 % -28.80 % -47.32 % -74.67 % -28.87 %
1Y -34.64 % -73.19 % -31.08 % -98.63 % -52.27 % -92.07 % -27.43 % -53.09 % -69.00 % -45.88 %
3Y -84.74 % -88.67 % -96.32 % -100.00 % -56.97 % -98.21 % -92.57 % -79.29 % -96.20 % -79.77 %
5Y -96.00 % -99.65 % -99.02 % -100.00 % -90.28 % -99.90 % -92.41 % -99.07 % -99.29 % -96.39 %
10Y -96.00 % -99.85 % -100.00 % -100.00 % -99.63 % -99.99 % -92.41 % -99.07 % -99.29 % -98.35 %
From the beginning -96.00 % -99.85 % -99.29 % -100.00 % -99.88 % -100.00 % -92.41 % -99.07 % -99.29 % -89.78 %

Dividend

Bolt Biotherapeutics, Inc.